Skip to content
MedsAcross

Medicine

Griseofulvin 125 mg tablet

Griseofulvin · Oral
Available on requestPrescription onlyUS FDAGeneric name

Griseofulvin 125 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Griseofulvin
Brand
Sold under the generic name
Strength
125 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 2 more
Manufacturers
Amneal Pharmaceuticals of New YorkSandozSigmapharm Laboratories
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D01AA08 Griseofulvin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
15 November 2012
Identifiers
RxCUI 239239, 242831DailyMed set ID 37b4d132-84f1-4394-b468-7e74eeec61eb, f4fa0eb9-bd6a-4ea2-b565-e0db88aa1ebd, f21314eb-3581-4e06-9fe7-8239cc80ba11NDC 42794-013, 0781-5827, 0115-1724Application ANDA202545, ANDA202805, ANDA204371

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, coated in 1 bottle, plastic0115-1724-01Amneal Pharmaceuticals of New York29 September 2014
500 tablet, coated in 1 bottle, plastic0115-1724-02Amneal Pharmaceuticals of New York29 September 2014
100 tablet, coated in 1 bottle0781-5827-01Sandoz1 April 2020
500 tablet, coated in 1 bottle0781-5827-05Sandoz1 April 2020
30 tablet in 1 bottle42794-013-08Sigmapharm Laboratories11 May 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Griseofulvin 125 mg tablet.

Compare 1

Other strengths and forms of Griseofulvin

Clinical summary

Griseofulvin is a tubulin inhibiting agent indicated for the treatment of ringworm infections, tinea corporis (ringworm of the body), tinea pedis (athlete's foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber's itch). MedsAcross supplies Griseofulvin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Griseofulvin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Griseofulvin 125 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.